ARVEE — Arvee Laboratories (India) Share Price
0.000.00%
Last trade - 00:00- IN₹2.13bn
- IN₹2.08bn
- IN₹384.87m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 6.82 | ||
| Price to Tang. Book | 6.82 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 5.54 | ||
| EV to EBITDA | 57.68 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 7.34% | ||
| Return on Equity | 7.11% | ||
| Operating Margin | 6.4% | ||
Financial Summary
| Year End 31st Mar | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 473.75 | 403.27 | 613.47 | 303.45 | 384.87 | n/a | n/a | -3.26% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +20.9 | -6.36 | +63.45 | -74.59 | +105.26 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Arvee Laboratories (India) Limited is an India-based company engaged in manufacturing of specialized chemicals. The Company's product categories include polymer modifiers, contrast media intermediates and drug intermediates. Its polymer modifiers products include Dimethyl 5-Sodiosulfoisophthalate, 5-Sulfoisophthalic Acid Mono Sodium Salt, 5-Sulfoisophthalic Acid Mono Lithium Salt and 5-Sodiosulfo-Bis-(B-Hydroxyethyl)-Isophthalate. The Company's contrast media intermediates products include 5-Nitroisophthalic acid, Dimethyl 5-Nitroisophthalate, Monomethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic acid, 5-Aminoisophthalic acid, Dimethyl 5-Aminoisophthalate, and 3,5-Diamino Benzoic Acid. Its drug intermediates products include 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, 4-Amino Pyridine and 2-Chloro-5-Nitrobenzoic Acid.
Directors
- Maulesh Raval CFO (46)
- Neelam Chotrani CCO (27)
- Shalin Patel MDR (43)
- Shalin Chokshi EDR (33)
- Saumil Chokshi NED (39)
- Chandrakala Bhatt NID (69)
- Vishal Mehta NID (43)
- Amishkumar Shah NID (44)
- Last Annual
- March 31st, 2025
- Last Interim
- March 31st, 2025
- Incorporated
- January 27th, 2012
- Public Since
- February 22nd, 2018
- No. of Employees
- 65
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 11,020,000
- Address
- 403, Entice Building,, Opposite Jayantil, AHMEDABAD, 380058
- Web
- http://arveelabs.com/
- Phone
- +91 2717430479
- Auditors
- Nirav Patel & Co.
Upcoming Events for ARVEE
Q2 2026 Arvee Laboratories (India) Ltd Earnings Release
Similar to ARVEE
20 Microns
National Stock Exchange of India
Aarti Industries
National Stock Exchange of India
Aarti Surfactants
National Stock Exchange of India
Abm International
National Stock Exchange of India
Acutaas Chemicals
National Stock Exchange of India
FAQ
What is the Arvee Laboratories (India) share price?
As of Today at 19:20 UTC, shares in Arvee Laboratories (India) are trading at IN₹193.50. This share price information is delayed by 15 minutes.
How has the Arvee Laboratories (India) share price performed this year?
Shares in Arvee Laboratories (India) last closed at IN₹193.50 and the price had moved by +4.65% over the past 365 days. In terms of relative price strength the Arvee Laboratories (India) share price has outperformed the S&P BSE 100 Index by +2.55% over the past year.
What are the analyst and broker recommendations for Arvee Laboratories (India)?
There is no consensus recommendation for this security.
Find out moreWhat is the Arvee Laboratories (India) dividend yield?
Arvee Laboratories (India) does not currently pay a dividend.
Does Arvee Laboratories (India) pay a dividend?
Arvee Laboratories (India) does not currently pay a dividend.
When does Arvee Laboratories (India) next pay dividends?
Arvee Laboratories (India) does not currently pay a dividend.
How do I buy Arvee Laboratories (India) shares?
To buy shares in Arvee Laboratories (India) you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Arvee Laboratories (India)?
As of the previous close price of IN₹193.50, shares in Arvee Laboratories (India) had a market capitalisation of IN₹2.13bn.
Where are Arvee Laboratories (India) shares listed?
Here are the trading details for Arvee Laboratories (India):
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: ARVEE
What kind of share is Arvee Laboratories (India)?
Based on an overall assessment of its quality, value and momentum Arvee Laboratories (India) is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Arvee Laboratories (India) share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Arvee Laboratories (India) share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Arvee Laboratories (India). Over the past six months, its share price has outperformed the S&P BSE 100 Index by +9.22%.
As of the last closing price of IN₹193.50, shares in Arvee Laboratories (India) were trading +18.02% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Arvee Laboratories (India) PE Ratio?
The Arvee Laboratories (India) PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹193.50.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Arvee Laboratories (India)?
Arvee Laboratories (India)'s management team is headed by:
- Maulesh Raval - CFO
- Neelam Chotrani - CCO
- Shalin Patel - MDR
- Shalin Chokshi - EDR
- Saumil Chokshi - NED
- Chandrakala Bhatt - NID
- Vishal Mehta - NID
- Amishkumar Shah - NID